News
University of Minnesota announces clinical trial for opioid vaccine
Drug Discovery & Development | September 7, 2021
The University of Minnesota Medical School has developed a therapeutic vaccine for opioid use disorder that is the subject of a new Phase 1 randomized placebo-controlled clinical trial. Marco Pravetoni, PhD, is leading the drug discovery research and will join the UW Medicine Garvey Institute for Brain Health Solutions in 2022.
Feature
Pamela Y. Collins appointed to the National Advisory Mental Health Council
June 30, 2021
Pamela Y. Collins, MD, MPH, who holds a joint professorship in psychiatry and global health, has been appointed to the prestigious National Institute of Mental Health’s National Advisory Mental Health Council (NAMHC).
Events
Re-Imagining Behavioral Health: Race, Equity and Social Justice Conference
Sept 23-24, 2021
Sponsored by the Behavioral Health Institute at Harborview Medical Center, this 2nd annual conference will feature speakers Dr. Caprice Hollins and Senator Joe Nguyen. More information and registration information coming soon.
